The Robot Rally is in Full Swing: Rapid Growth on the Horizon. BNGO Generates Over 3% Quick Profit with 2 Robots at Once. Swing-Trader-High-Volatility-Stocks-for-Active-Trading-TA-FA https://Swing-trader-Volatility-Balanced-Strategy-v-2-TA And that's just the tip of the iceberg. This week, all the robots combined have earned over 4%, surpassing all possible indices. These robots are designed for traders seeking high-volatility stocks while minimizing drawdowns during downtrends. Our AI robots utilize a range of technical indicators to identify reversal points in uptrends, allowing for balanced short and long positions to prevent significant drawdowns.
These robots are ideal for active traders capable of monitoring 40-50 trades simultaneously. With an average trade duration of one day, users can effectively utilize their capital without being tied up in prolonged trades.
To select stocks, our robots employ a proprietary method developed by our team of quants, evaluating the strength and quality of momentum in the most active stocks in the US market. A sophisticated algorithm, incorporating a pool of technical indicators processed through neural networks, determines entry points for positions.
Once a trade is initiated, our AI robots place a fixed "Take Profit" order at 3.5% of the position's opening price. For exiting a position, the robots utilize two options: a fixed stop loss at 3% of the opening price and a flexible trailing stop, helping preserve most of the profits if the market reverses. Subscribe to our robots and enjoy swift profitability.
BNGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where BNGO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for BNGO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for BNGO crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 96 cases where BNGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on September 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNGO as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BNGO turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
BNGO moved below its 50-day moving average on September 15, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.184) is normal, around the industry mean (11.003). P/E Ratio (0.026) is within average values for comparable stocks, (57.978). BNGO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.758). BNGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.150) is also within normal values, averaging (16.987).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of technologies for analysis of large biological molecules
Industry PharmaceuticalsOther